This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Andrea Cossarizza

Andrea Cossarizza

Past President (2020-2022)

Andrea Cossarizza holds a Master’s degree in Medicine and Surgery from the University of Padua and a PhD in Oncology from the Universities of Bologna and Modena, with a Specialization in Clinical Pathology and Immunohematology from the University of Modena and Reggio Emilia. As a medical student, his interest in immunology led him to the Basel Institute of Immunology and the New York University Medical Center. After working at several different institutions (Charing Cross Sunley Res. Ctr., London; Univ. Cochin, Paris; University of California at Los Angeles - UCLA), he became the Associate Professor of General Pathology and Immunology at the University of Modena and Reggio Emilia in 1998 and was appointed Full Professor in 2010. He is also Director of the School of Specialization in Clinical Pathology and Clinical Biochemistry and Vice Dean of the School of Medicine.

His current scientific interests are the characterization of the immune response and the search for predictive markers in patients treated with biological drugs; immune alterations during different human diseases, in particular HIV infection and autoimmune disorders; immunological changes during aging and longevity; and role of mitochondria during apoptosis and importance of mitochondrial DNA in a variety of pathologies. In the past, he also studied the biological effects of non-ionizing radiations (pulsed magnetic fields) and the ontogenesis and phylogenesis of the immune system.

Dr. Cossarizza has published 320 papers in peer-reviewed international journals with a total impact factor of over 1,350 (including Science, Nature Communications, Nature Protocols, The Lancet, Proc. Natl. Acad. Sci. USA). He has also been cited approximately 30,000 times with an H index of 75.

Since 1997, he has participated in several activities and committees in ISAC, and in 2016 he was elected President.